6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T63610 | SPR7 | ||
SPR7 is a potent and selective rhodesain inhibitor (Ki: 0.51 nM). SPR7 exhibited antiparasitic effects against T. b. brucei (EC50: 1.65 μM). | |||
T12992 | SPR741 acetate | SPR741 acetate,NAB741 acetate,SPR741 acetate (1179330-52-9 free base) | Antibacterial |
SPR741 acetate is a cationic peptide derived from polymyxin B. It exhibits antimicrobial activity against gram-negative bacteria by inhibiting severe gram-negative bacterial sensory by increasing the permeability of the ... | |||
T13326 | SPR719 | VXc-486 | Others |
SPR719 is an inhibitor of gyrase B, has bactericidal activity. | |||
TP1089 | SPR741 TFA (1179330-52-9 free base) | NAB741 TFA,SPR741 TFA | |
SPR741 TFA (NAB741 TFA) is a cationic peptide derived from polymyxin B and is a potentiator molecule. | |||
T75994 | SPR741 TFA | ||
SPR741 TFA (NAB741 TFA), a cationic peptide derived from polymyxin B, acts as a potentiator molecule that enhances the permeability of Gram-negative bacteria's outer membrane, thereby facilitating the treatment of severe... | |||
TP1090 | SPR741 | NAB741 | |
SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections. |